ArticleEuropean urology2014

The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer.

Michael T Schweizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.